286 related articles for article (PubMed ID: 33062715)
1. Increased Brain Iron Deposition in the Putamen in Patients with Type 2 Diabetes Mellitus Detected by Quantitative Susceptibility Mapping.
Li J; Zhang Q; Zhang N; Guo L
J Diabetes Res; 2020; 2020():7242530. PubMed ID: 33062715
[TBL] [Abstract][Full Text] [Related]
2. Increased Brain Iron Detection by Voxel-Based Quantitative Susceptibility Mapping in Type 2 Diabetes Mellitus Patients With an Executive Function Decline.
Li J; Zhang Q; Zhang N; Guo L
Front Neurosci; 2020; 14():606182. PubMed ID: 33519360
[TBL] [Abstract][Full Text] [Related]
3. Brain iron deposition in type 2 diabetes mellitus with and without mild cognitive impairment-an in vivo susceptibility mapping study.
Yang Q; Zhou L; Liu C; Liu D; Zhang Y; Li C; Shang Y; Wei X; Li C; Wang J
Brain Imaging Behav; 2018 Oct; 12(5):1479-1487. PubMed ID: 29297155
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent changes in brain iron deposition and volume in deep gray matter nuclei using quantitative susceptibility mapping.
Li G; Tong R; Zhang M; Gillen KM; Jiang W; Du Y; Wang Y; Li J
Neuroimage; 2023 Apr; 269():119923. PubMed ID: 36739101
[TBL] [Abstract][Full Text] [Related]
5. Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures.
Lim IA; Faria AV; Li X; Hsu JT; Airan RD; Mori S; van Zijl PC
Neuroimage; 2013 Nov; 82():449-69. PubMed ID: 23769915
[TBL] [Abstract][Full Text] [Related]
6. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
[TBL] [Abstract][Full Text] [Related]
7. Quantitative susceptibility mapping for iron monitoring of multiple subcortical nuclei in type 2 diabetes mellitus: a systematic review and meta-analysis.
Mohammadi S; Ghaderi S; Sayehmiri F; Fathi M
Front Endocrinol (Lausanne); 2024; 15():1331831. PubMed ID: 38510699
[TBL] [Abstract][Full Text] [Related]
8. Regional high iron deposition on quantitative susceptibility mapping correlates with cognitive decline in type 2 diabetes mellitus.
Hu R; Gao B; Tian S; Liu Y; Jiang Y; Li W; Li Y; Song Q; Wang W; Miao Y
Front Neurosci; 2023; 17():1061156. PubMed ID: 36793541
[TBL] [Abstract][Full Text] [Related]
9. Cerebral Microbleeds Are Associated With Increased Brain Iron and Cognitive Impairment in Patients With Cerebral Small Vessel Disease: A Quantitative Susceptibility Mapping Study.
Li J; Nguyen TD; Zhang Q; Guo L; Wang Y
J Magn Reson Imaging; 2022 Sep; 56(3):904-914. PubMed ID: 35099829
[TBL] [Abstract][Full Text] [Related]
10. Increased iron deposition of deep cerebral gray matter structures in hemodialysis patients: A longitudinal study using quantitative susceptibility mapping.
Chai C; Wang H; Liu S; Chu ZQ; Li J; Qian T; Haacke EM; Xia S; Shen W
J Magn Reson Imaging; 2019 Mar; 49(3):786-799. PubMed ID: 30291651
[TBL] [Abstract][Full Text] [Related]
11. Spatiotemporal variations of magnetic susceptibility in the deep gray matter nuclei from 1 month to 6 years: A quantitative susceptibility mapping study.
Ning N; Liu C; Wu P; Hu Y; Zhang W; Zhang L; Li M; Gho SM; Kim DH; Guo H; Yang J; Jin C
J Magn Reson Imaging; 2019 Jun; 49(6):1600-1609. PubMed ID: 30569483
[TBL] [Abstract][Full Text] [Related]
12. Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer's Disease.
Du L; Zhao Z; Cui A; Zhu Y; Zhang L; Liu J; Shi S; Fu C; Han X; Gao W; Song T; Xie L; Wang L; Sun S; Guo R; Ma G
ACS Chem Neurosci; 2018 Jul; 9(7):1849-1857. PubMed ID: 29722955
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Susceptibility Mapping of Brain Iron Relating to Cognitive Impairment in Hypertension.
Qin Z; Wu W; Liu D; Zheng C; Kang J; Zhou H; Meng X; Haacke EM; Wang L
J Magn Reson Imaging; 2022 Aug; 56(2):508-515. PubMed ID: 34989062
[TBL] [Abstract][Full Text] [Related]
14. Iron Deposition Characteristics of Deep Gray Matter in Elderly Individuals in the Community Revealed by Quantitative Susceptibility Mapping and Multiple Factor Analysis.
Li J; Zhang Q; Che Y; Zhang N; Guo L
Front Aging Neurosci; 2021; 13():611891. PubMed ID: 33935681
[TBL] [Abstract][Full Text] [Related]
15. Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals.
Hagemeier J; Ramanathan M; Schweser F; Dwyer MG; Lin F; Bergsland N; Weinstock-Guttman B; Zivadinov R
Neuroimage Clin; 2018; 17():530-540. PubMed ID: 29201641
[TBL] [Abstract][Full Text] [Related]
16. Evaluating iron deposition in gray matter nuclei of patients with unilateral middle cerebral artery stenosis using quantitative susceptibility mapping.
Mao H; Dou W; Chen K; Wang X; Wang X; Guo Y; Zhang C
Neuroimage Clin; 2022; 34():103021. PubMed ID: 35500369
[TBL] [Abstract][Full Text] [Related]
17. Characterizing Brain Iron Deposition in Patients with Subcortical Vascular Mild Cognitive Impairment Using Quantitative Susceptibility Mapping: A Potential Biomarker.
Sun Y; Ge X; Han X; Cao W; Wang Y; Ding W; Cao M; Zhang Y; Xu Q; Zhou Y; Xu J
Front Aging Neurosci; 2017; 9():81. PubMed ID: 28424610
[TBL] [Abstract][Full Text] [Related]
18. Different iron deposition patterns in hemodialysis patients with and without restless legs syndrome: a quantitative susceptibility mapping study.
Wang H; Han X; Jin M; Wang LY; Diao ZL; Guo W; Zhang P; Wang Z; Ding HY; Lv H; Zhang ZY; Zhao PF; Li J; Yang ZH; Liu WH; Wang ZC
Sleep Med; 2020 May; 69():34-40. PubMed ID: 32045852
[TBL] [Abstract][Full Text] [Related]
19. Iron leakage owing to blood-brain barrier disruption in small vessel disease CADASIL.
Uchida Y; Kan H; Sakurai K; Arai N; Inui S; Kobayashi S; Kato D; Ueki Y; Matsukawa N
Neurology; 2020 Sep; 95(9):e1188-e1198. PubMed ID: 32586899
[TBL] [Abstract][Full Text] [Related]
20. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping.
Bilgic B; Pfefferbaum A; Rohlfing T; Sullivan EV; Adalsteinsson E
Neuroimage; 2012 Feb; 59(3):2625-35. PubMed ID: 21925274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
